These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 21908444)

  • 1. Thymus-derived rather than tumor-induced regulatory T cells predominate in brain tumors.
    Wainwright DA; Sengupta S; Han Y; Lesniak MS
    Neuro Oncol; 2011 Dec; 13(12):1308-23. PubMed ID: 21908444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helios+ and Helios- cells coexist within the natural FOXP3+ T regulatory cell subset in humans.
    Himmel ME; MacDonald KG; Garcia RV; Steiner TS; Levings MK
    J Immunol; 2013 Mar; 190(5):2001-8. PubMed ID: 23359504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IDO expression in brain tumors increases the recruitment of regulatory T cells and negatively impacts survival.
    Wainwright DA; Balyasnikova IV; Chang AL; Ahmed AU; Moon KS; Auffinger B; Tobias AL; Han Y; Lesniak MS
    Clin Cancer Res; 2012 Nov; 18(22):6110-21. PubMed ID: 22932670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma.
    Sayour EJ; McLendon P; McLendon R; De Leon G; Reynolds R; Kresak J; Sampson JH; Mitchell DA
    Cancer Immunol Immunother; 2015 Apr; 64(4):419-27. PubMed ID: 25555571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treg depletion inhibits efficacy of cancer immunotherapy: implications for clinical trials.
    Curtin JF; Candolfi M; Fakhouri TM; Liu C; Alden A; Edwards M; Lowenstein PR; Castro MG
    PLoS One; 2008 Apr; 3(4):e1983. PubMed ID: 18431473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hijacking Sexual Immuno-Privilege in GBM-An Immuno-Evasion Strategy.
    Sharpe MA; Baskin DS; Jenson AV; Baskin AM
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutting edge: epigenetic regulation of Foxp3 defines a stable population of CD4+ regulatory T cells in tumors from mice and humans.
    Waight JD; Takai S; Marelli B; Qin G; Hance KW; Zhang D; Tighe R; Lan Y; Lo KM; Sabzevari H; Hofmeister R; Wilson NS
    J Immunol; 2015 Feb; 194(3):878-82. PubMed ID: 25548231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas.
    Heimberger AB; Abou-Ghazal M; Reina-Ortiz C; Yang DS; Sun W; Qiao W; Hiraoka N; Fuller GN
    Clin Cancer Res; 2008 Aug; 14(16):5166-72. PubMed ID: 18698034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural and inducible Tregs in swine: Helios expression and functional properties.
    Käser T; Mair KH; Hammer SE; Gerner W; Saalmüller A
    Dev Comp Immunol; 2015 Apr; 49(2):323-31. PubMed ID: 25511662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell receptor transgenic lymphocytes infiltrating murine tumors are not induced to express foxp3.
    Quatromoni JG; Morris LF; Donahue TR; Wang Y; McBride W; Chatila T; Economou JS
    J Hematol Oncol; 2011 Nov; 4():48. PubMed ID: 22112546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in Expression Level of Helios and Neuropilin-1 Do Not Distinguish Thymus-Derived from Extrathymically-Induced CD4+Foxp3+ Regulatory T Cells.
    Szurek E; Cebula A; Wojciech L; Pietrzak M; Rempala G; Kisielow P; Ignatowicz L
    PLoS One; 2015; 10(10):e0141161. PubMed ID: 26495986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic biomarkers of T-cells in human glioma.
    Wiencke JK; Accomando WP; Zheng S; Patoka J; Dou X; Phillips JJ; Hsuang G; Christensen BC; Houseman EA; Koestler DC; Bracci P; Wiemels JL; Wrensch M; Nelson HH; Kelsey KT
    Epigenetics; 2012 Dec; 7(12):1391-402. PubMed ID: 23108258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance and mechanism of Treg infiltration in human brain tumors.
    Jacobs JF; Idema AJ; Bol KF; Grotenhuis JA; de Vries IJ; Wesseling P; Adema GJ
    J Neuroimmunol; 2010 Aug; 225(1-2):195-9. PubMed ID: 20537408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eliminating roles for T-bet and IL-2 but revealing superior activation and proliferation as mechanisms underpinning dominance of regulatory T cells in tumors.
    Colbeck EJ; Hindley JP; Smart K; Jones E; Bloom A; Bridgeman H; McPherson RC; Turner DG; Ladell K; Price DA; O'Connor RA; Anderton SM; Godkin AJ; Gallimore AM
    Oncotarget; 2015 Sep; 6(28):24649-59. PubMed ID: 26433463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutting edge: expression of TNFR2 defines a maximally suppressive subset of mouse CD4+CD25+FoxP3+ T regulatory cells: applicability to tumor-infiltrating T regulatory cells.
    Chen X; Subleski JJ; Kopf H; Howard OM; Männel DN; Oppenheim JJ
    J Immunol; 2008 May; 180(10):6467-71. PubMed ID: 18453563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local Application of Autologous Platelet-Rich Fibrin Patch (PRF-P) Suppresses Regulatory T Cell Recruitment in a Murine Glioma Model.
    Panek WK; Pituch KC; Miska J; Kim JW; Rashidi A; Kanojia D; Lopez-Rosas A; Han Y; Yu D; Chang CL; Kane JR; Zhang P; Cordero A; Lesniak MS
    Mol Neurobiol; 2019 Jul; 56(7):5032-5040. PubMed ID: 30460615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Thymic Output of Effector CD4
    Zhao Y; Alard P; Kosiewicz MM
    J Immunol Res; 2019; 2019():8785263. PubMed ID: 31281853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas.
    Yan J; Kong LY; Hu J; Gabrusiewicz K; Dibra D; Xia X; Heimberger AB; Li S
    J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 25971300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treg depletion potentiates checkpoint inhibition in claudin-low breast cancer.
    Taylor NA; Vick SC; Iglesia MD; Brickey WJ; Midkiff BR; McKinnon KP; Reisdorf S; Anders CK; Carey LA; Parker JS; Perou CM; Vincent BG; Serody JS
    J Clin Invest; 2017 Sep; 127(9):3472-3483. PubMed ID: 28825599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoid hormone differentially modulates the in vitro expansion and cytokine profile of thymic and splenic Treg cells.
    Pap R; Ugor E; Litvai T; Prenek L; Najbauer J; Németh P; Berki T
    Immunobiology; 2019 Mar; 224(2):285-295. PubMed ID: 30612787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.